PT Darya-Varia Laboratoria Tbk (DVLA.JK)
IDR 1450.0
(2.11%)
IDR 1450.0
(2.11%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 452.64 Billion IDR | -10.9% |
| 2022 | 507.99 Billion IDR | 18.15% |
| 2021 | 429.97 Billion IDR | 14.84% |
| 2020 | 374.42 Billion IDR | 12.18% |
| 2019 | 333.78 Billion IDR | 18.91% |
| 2018 | 280.69 Billion IDR | 37.69% |
| 2017 | 203.86 Billion IDR | -2.82% |
| 2016 | 209.77 Billion IDR | 5.6% |
| 2015 | 198.65 Billion IDR | -12.5% |
| 2014 | 227.04 Billion IDR | 9.85% |
| 2013 | 206.68 Billion IDR | 55.61% |
| 2012 | 132.82 Billion IDR | 12.14% |
| 2011 | 118.44 Billion IDR | 21.7% |
| 2010 | 97.32 Billion IDR | -18.03% |
| 2009 | 118.73 Billion IDR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 429.59 Billion IDR | 6.46% |
| 2024 Q1 | 448.77 Billion IDR | -0.86% |
| 2024 Q2 | 403.54 Billion IDR | -10.08% |
| 2023 Q4 | 452.64 Billion IDR | -15.03% |
| 2023 Q1 | 491.02 Billion IDR | -3.34% |
| 2023 Q2 | 508.41 Billion IDR | 3.54% |
| 2023 FY | 452.64 Billion IDR | -10.9% |
| 2023 Q3 | 532.73 Billion IDR | 4.78% |
| 2022 Q1 | 402.34 Billion IDR | -6.43% |
| 2022 Q2 | 426.57 Billion IDR | 6.02% |
| 2022 Q3 | 468.01 Billion IDR | 9.71% |
| 2022 Q4 | 507.99 Billion IDR | 8.54% |
| 2022 FY | 507.99 Billion IDR | 18.15% |
| 2021 Q1 | 349.45 Billion IDR | -6.67% |
| 2021 Q4 | 429.97 Billion IDR | 29.87% |
| 2021 Q3 | 331.09 Billion IDR | -3.79% |
| 2021 Q2 | 344.13 Billion IDR | -1.52% |
| 2021 FY | 429.97 Billion IDR | 14.84% |
| 2020 Q4 | 374.42 Billion IDR | -9.1% |
| 2020 Q1 | 320.77 Billion IDR | -3.9% |
| 2020 Q2 | 383.53 Billion IDR | 19.57% |
| 2020 FY | 374.42 Billion IDR | 12.18% |
| 2020 Q3 | 411.89 Billion IDR | 7.39% |
| 2019 FY | 333.78 Billion IDR | 18.91% |
| 2019 Q2 | 308.1 Billion IDR | 1.73% |
| 2019 Q4 | 333.78 Billion IDR | 15.84% |
| 2019 Q1 | 302.87 Billion IDR | 7.9% |
| 2019 Q3 | 288.13 Billion IDR | -6.48% |
| 2018 Q3 | 275.73 Billion IDR | 5.49% |
| 2018 Q2 | 261.39 Billion IDR | 15.64% |
| 2018 FY | 280.69 Billion IDR | 37.69% |
| 2018 Q1 | 226.04 Billion IDR | 10.88% |
| 2018 Q4 | 280.69 Billion IDR | 1.8% |
| 2017 Q1 | 236.37 Billion IDR | 12.68% |
| 2017 Q2 | 229.97 Billion IDR | -2.71% |
| 2017 Q3 | 206.98 Billion IDR | -10.0% |
| 2017 Q4 | 203.86 Billion IDR | -1.51% |
| 2017 FY | 203.86 Billion IDR | -2.82% |
| 2016 FY | 209.77 Billion IDR | 5.6% |
| 2016 Q4 | 209.77 Billion IDR | -10.75% |
| 2016 Q2 | 236.37 Billion IDR | 3.36% |
| 2016 Q3 | 235.04 Billion IDR | -0.56% |
| 2016 Q1 | 228.68 Billion IDR | 15.12% |
| 2015 Q3 | 217.14 Billion IDR | -3.06% |
| 2015 FY | 198.65 Billion IDR | -12.5% |
| 2015 Q4 | 198.65 Billion IDR | -8.51% |
| 2015 Q1 | 222.53 Billion IDR | -1.99% |
| 2015 Q2 | 224 Billion IDR | 0.66% |
| 2014 Q1 | 205.67 Billion IDR | -0.49% |
| 2014 Q3 | 239.74 Billion IDR | 2.89% |
| 2014 Q4 | 227.04 Billion IDR | -5.3% |
| 2014 Q2 | 233.01 Billion IDR | 13.3% |
| 2014 FY | 227.04 Billion IDR | 9.85% |
| 2013 Q2 | 154.9 Billion IDR | 11.01% |
| 2013 Q3 | 186.64 Billion IDR | 20.49% |
| 2013 Q4 | 206.68 Billion IDR | 10.73% |
| 2013 FY | 206.68 Billion IDR | 55.61% |
| 2013 Q1 | 139.53 Billion IDR | 5.06% |
| 2012 Q4 | 132.82 Billion IDR | -13.47% |
| 2012 FY | 132.82 Billion IDR | 12.14% |
| 2012 Q3 | 153.49 Billion IDR | 0.0% |
| 2011 FY | 118.44 Billion IDR | 21.7% |
| 2010 FY | 97.32 Billion IDR | -18.03% |
| 2009 FY | 118.73 Billion IDR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| PT Merck Tbk | 377.19 Billion IDR | -20.002% |
| PT Phapros, Tbk | 301.13 Billion IDR | -50.315% |
| PT Pyridam Farma Tbk | 225.48 Billion IDR | -100.744% |
| PT Industri Jamu dan Farmasi Sido Muncul Tbk | 408.45 Billion IDR | -10.819% |
| PT Tempo Scan Pacific Tbk | 1865.03 Billion IDR | 75.73% |